Company Profile of Dalian Yongda Suli Pharma Co., Ltd.

Dalian Yongda Suli Pharmaceutical Co., Ltd. is a joint-stock company jointly funded by Jiangsu Yongda Pharmaceutical Co., Ltd. and Suli pharmaceutical technology Jiangyin Co., Ltd., a wholly-owned subsidiary of Jiangsu Suli fine chemical industry. It is located on Changxing Island, a beautiful island in the west of Liaodong Peninsula. IThe whole area of the plant is about 175600M2.t mainly produces pharmaceutical raw materials and pharmaceutical intermediates, mainly including pharmaceutical intermediates such as 1-cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinoline carboxylic acid ethyl ester , s - (-) - indoline-2-carboxylic acid, octahydro-indole-2-carboxylic acid and trans-4-isopropylcyclohexylcarboxylic acid, as well as raw materials such as gatifloxacin, Nateglinide, moxifloxacin hydrochloride and perindopril TERT butylamine salt.